Clinical Trial

Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease

Study acronym: PREDICT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-03.
Trial Details
NCT Number NCT07166588
Lead Sponsor Seoul National University Hospital
Conditions Crohn Disease (CD), Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease)
Enrollment 2,000 participants
Start Date 2021-01-20
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-15